Last updated: November 17, 2023
Sponsor: Guangzhou 8th People's Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hiv
Pneumonia
Soft Tissue Infections
Treatment
Pathogen metagenomic next-generation sequencing
Clinical Study ID
NCT06145841
GZ8H-202322259s
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Confirmed HIV infection;
- Progression to AIDS stage: CD4+ count <200 cells/ul and/or occurrence of AIDSopportunistic infections;
- Age between 18 and 65 years;
- Meeting the diagnosis of severe pneumonia or septic shock:
- The criteria for severe pneumonia diagnosis refer to the 2021 ATS (AmericanThoracic Society) and IDSA (Infectious Diseases Society of America) guidelinesfor the treatment of community-acquired pneumonia;
- The criteria for septic shock refer to the Chinese Society of Critical CareMedicine's "Chinese Guidelines for the Emergency Treatment of Sepsis/Septic Shock (2018).
Exclusion
Exclusion Criteria:
- Coexisting central nervous system lesions, severe liver disease, or cirrhosis;
- Concurrent AIDS-related or unrelated tumors;
- Women who are pregnant or breastfeeding;
- Severe underlying diseases of the heart, lungs, liver, kidneys, etc.;
- Alcohol abuse or drug use;
- The researcher believes that the overall condition of the subject affects theevaluation and completion of the trial.
Study Design
Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Pathogen metagenomic next-generation sequencing
Phase:
Study Start date:
October 23, 2023
Estimated Completion Date:
October 23, 2027
Study Description
Connect with a study center
Linghua Li
Guangzhou, Guangdong 510060
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.